Prediction Accuracy for Langeal Mask Unique TM Size in Pediatric Patient

Sponsor
Indonesia University (Other)
Overall Status
Completed
CT.gov ID
NCT04215302
Collaborator
(none)
66
1
1.6
41

Study Details

Study Description

Brief Summary

the study aimed to know the accuracy for laryngeal mask unique TM size to Malay pediatric race according to weight measurement recommended by manufacturer

Condition or Disease Intervention/Treatment Phase
  • Device: laryngeal mask

Detailed Description

sixty-six pediatric subjects aged between 1 - 10 years old underwent general anesthesia using laryngeal mask Unique TM. Laryngeal mask inserted using the size based on subject's weight. Effectivity was confirmed if there is no air sound from patient's mouth, airway seal pressure ≥20 cmH2O, maximum inspiration pressure was ≤ 20 cmH2O, difference in expiration and inspiration tidal volume less than 5%, and there is no cuff appear in mouth.

Study Design

Study Type:
Observational
Actual Enrollment :
66 participants
Observational Model:
Case-Crossover
Time Perspective:
Cross-Sectional
Official Title:
Prediction Accuracy for Langeal Mask Unique TM Size in Melayu Pediatric Population According to Weight Meissurement
Actual Study Start Date :
Sep 17, 2019
Actual Primary Completion Date :
Nov 5, 2019
Actual Study Completion Date :
Nov 5, 2019

Arms and Interventions

Arm Intervention/Treatment
laryngeal mask size

laryngeal mask size determines according to weight measurement

Device: laryngeal mask
the size of laryngeal mask given to the patient was based on patient's weight measurement

Outcome Measures

Primary Outcome Measures

  1. successful insertion of laryngeal mask [3 minutes]

    observe the sign of successful insertion of laryngeal mask

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged 1 -10 years old

  • Malay race

  • scheduled for general anesthesia procedure with laryngeal mask

Exclusion Criteria:
  • disagree to be included in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Indonesia University Jakarta DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University

Investigators

  • Principal Investigator: Christopher Kapuangan, MD, Indonesia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christopher Kapuangan, MD, Indonesia University
ClinicalTrials.gov Identifier:
NCT04215302
Other Study ID Numbers:
  • IndonesiaUAnes053
First Posted:
Jan 2, 2020
Last Update Posted:
Jan 2, 2020
Last Verified:
Dec 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 2, 2020